› Forums › General Melanoma Community › Ipi+Nivo approved in UK
- This topic has 6 replies, 1 voice, and was last updated 8 years, 11 months ago by
MoiraM.
- Post
-
- June 18, 2016 at 12:40 pm
In the news this morning:
The National Institute for Health and Care Excellence (NICE) surprised industry-watchers with a speedy thumbs up for the one-two punch of Bristol’s Opdivo and Yervoy in advanced forms of the disease. And thanks to that verdict, patients in England will be the first to gain access to the immunotherapy pairing, which won EU approval just last month.
- Replies
-
-
- June 18, 2016 at 1:27 pm
Yes, things have moved on quickly. February only Ipi was on offer under the NHS in the UK. By the time I finished my course of Ipi, I was told that nivolumab was available and now the combination is available on the NHS.
Only for stage 4 though or for 'unresectable stage 3'.
-
- June 18, 2016 at 1:27 pm
Yes, things have moved on quickly. February only Ipi was on offer under the NHS in the UK. By the time I finished my course of Ipi, I was told that nivolumab was available and now the combination is available on the NHS.
Only for stage 4 though or for 'unresectable stage 3'.
-
- June 18, 2016 at 1:27 pm
Yes, things have moved on quickly. February only Ipi was on offer under the NHS in the UK. By the time I finished my course of Ipi, I was told that nivolumab was available and now the combination is available on the NHS.
Only for stage 4 though or for 'unresectable stage 3'.
-
- You must be logged in to reply to this topic.